Psilocybin may benefit individuals with cancer and major depression

Results from a phase II clinical trial indicate that psilocybin, a hallucinogenic chemical found in certain mushrooms of the genus Psiloybe, may benefit individuals with cancer and major depression.

Abcam agrees to $5.7B sale to Danaher amid founder’s push for a board seat

Danaher will buy Abcam, a research tools supplier relied upon by many biopharmas, for an enterprise value of about $5.7 billion, the companies announced Monday

August 29, 2023

New blood test could diagnose bile acid diarrhea

Most people have at some point in their life suffered an intestinal infection or food poisoning forcing them to stay close to the bathroom. It

July 5, 2023

Over half of world’s population not covered by essential healthcare services – Pharmaceutical Technology

The WHO and World Bank estimate that the slow progress towards UHC stated in the report is associated with the emergence of Covid-19. Credit: Chinnapong

September 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.